MENU
CAMP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Camp4 Therapeutics (CAMP) Ownership - Who owns Camp4 Therapeutics?

Camp4 Therapeutics Corp is a clinical stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases... Show more

Profile

Industry
N/A
Address
15635 Alton Parkway
Phone
+1 949 600-5600
Employees
644
Web
https://www.calamp.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
307.14M
P/E Ratio
N/A
Total Cash
75.26M
Projected Growth
0.10
Total Debt
6.35M
Revenue
3.8M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
1.45
Total Debt/Equity
N/A
Revenue/Share
0.08 USD as % of share price

Fundamentals

CAMP
Capitalization
307M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
75.3M
Total Cash/Share
1.45
Total Debt
6.35M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
0.10
Revenue/Share (as % of the share price)
0.08%
Revenue
3.8M
ROE
N/A
Book Value
58.7M
P/B Ratio
5.24
Cash Flow
N/A
Earnings
-10.85
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
9.83
Current Revenue Per Employee
14454.55
Dividends Per Share - Security
N/A
EBITDA
-51.63M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-99.11
Shares Held By Institutions
103M
Shares Outstanding - Current
51.9M
Total Liabilities
27.7M
Total Volume MTD
N/A
Value
N/A
Gain YTD
13.410
View a ticker or compare two or three
CAMP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
15635 Alton Parkway
Phone
+1 949 600-5600
Employees
644
Web
https://www.calamp.com